Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,345	1,917	1,245	672	428	418
Market Cap Growth	121.87%	54.01%	85.16%	57.27%	2.40%	-15.33%
Enterprise Value	5,297	1,949	1,247	501	263	311
Last Close Price	90.50	39.20	27.60	17.80	13.63	-
PS Ratio	13.29	5.89	7.38	9.32	25.41	-
PB Ratio	21.47	8.80	5.53	5.06	4.04	2.97
P/TBV Ratio	104.26	-	-	8.65	4.79	2.97
P/FCF Ratio	141.50	212.71	-	-	-	-
P/OCF Ratio	140.32	192.25	-	-	-	-
EV/Sales Ratio	13.23	5.99	7.39	6.95	15.62	-
EV/FCF Ratio	140.23	216.27	-	-	-	-
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02
Debt / FCF Ratio	7.19	34.05	-	-	-	-
Net Debt / Equity Ratio	-0.19	0.17	0.09	-1.05	-1.28	-1.33
Net Debt / EBITDA Ratio	3.23	-0.58	-0.22	1.17	0.89	2.20
Net Debt / FCF Ratio	-1.28	4.01	-0.31	1.24	1.16	2.56
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-
Inventory Turnover	4.16	3.65	3.38	3.50	-	-
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%
Return on Capital Employed (ROCE)	-6.70%	-16.10%	-19.50%	-45.50%	-68.80%	-46.90%
Earnings Yield	-0.66%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%
FCF Yield	0.71%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.